|
|
Title | Creator | Date |
1 |
|
A Pediatric Case of Anti-N-methyl-D-aspartate Receptor Encephalitis Associated With Optic Neuritis | Jia Yue You, MD, Caroline Lacroix, MD, Daniela Toffoli, MD | 2022-03 |
2 |
|
Alterations in the Retinal Vascular Network and Structure in MOG Antibody-Associated Disease: An Optical Coherence Tomography Angiography Study | Jian Yu, PhD, Yongheng Huang, PhD, Chao Quan, PhD, Lei Zhou, PhD, Jingzi ZhangBao, PhD, Kaicheng Wu, PhD, Yuan Zong, PhD, Xujiao Zhou, PhD, Min Wang, PhD | 2021-12 |
3 |
|
Atypical Optic Neuritis After COVID-19 Vaccination | Pathum Sookaromdee, PhD; Viroj Wiwanitkit, MD | 2023-03 |
4 |
|
Comparison of Visual Evoked Potentials in Patients Affected by Optic Neuritis From Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder | Thiago G. Filgueiras, MD, PhD, Maria K. Oyamada, MD, PhD, Kenzo Hokazono, MD, PhD, Leonardo P. Cunha, MD, PhD, Samira L. Apóstolos- Pereira, MD, PhD, Dagoberto Callegaro, MD, PhD, Mário L. R. Monteiro, MD, PhD | 2022-03 |
5 |
|
Cognitive Performance of Patients With Multiple Sclerosis and Optic Neuritis at Presentation | Ari Leshno, MD, Oded Sagiv, MD, Roy Aloni, PhD, Alon Skaat, MD, Anat Achiron, MD, Ruth Huna-Baron, MD | 2022-03 |
6 |
|
Development of a Prognostic Model for Predicting Multiple Sclerosis After Optic Neuritis: A Secondary Analysis of Data From the Optic Neuritis Treatment Trial | Wenjing Luo, MD, Xinlei Deng, MD, Xiaoyu Xu, MD, Ruitong Song, MB, Meifeng Luo, MB, Heather E. Moss, MD, PhD, Yi Du, MD | 2022-03 |
7 |
|
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis-A Review | Megha Kaushik, MBBS, Michael A. Burdon, MBBS | 2021-12 |
8 |
|
Optic Neuritis Associated With Tumor Necrosis Factor-Alpha Inhibitor Certolizumab | Ariel Chen, MD, Neil R. Miller, MD, Thomas M. Bosley, MD | 2021-12 |
9 |
|
Spontaneous Resolution of Optic Perineuritis | Cynthia Tung, MD, Nafiseh Hashemi, MD, Andrew G. Lee, MD | 2013-03 |
10 |
|
Detection of Thyroid Abnormalities in Aquaporin-4 Antibody-Seropositive Optic Neuritis Patients | Zhao, Shuo; Zhou, Huanfen; Peng, Xudong; Tan, Shaoying; Liu, Zihao; Chen, Tingjun; Xu, Quangang; Wei, Shihui | 2017-03 |
11 |
|
Antiaquaporin 4-Related Optic Neuritis and Myelitis Post-COVID-19 Infection | Pouriska B. Kivanany; Subahari Raviskanthan; Peter W. Mortensen; Andrew G. Lee | 2022-12 |
12 |
|
Infliximab-Induced Optic Perineuritis and Facial Myositis | Loulwah Mukharesh; Amanda Tinsley | 2022-12 |
13 |
|
Herpes Zoster Optic Neuropathy: Comment | Cindy Lam, MD, FRCSC | 2018-12 |
14 |
|
New Insights in Vanishing White Matter Disease: Isolated Bilateral Optic Neuropathy in Adult-Onset Disease: Response | Damien Biotti, MD, Jeanne Lajoie, MD, Fabrice Bonneville, MD, PhD, Simon Samaan, MD, Pierre Labauge, MD, PhD | 2018-12 |
15 |
|
Utilization of Visual Acuity Retroilluminated Charts for the Assessment of Afferent Visual System Dysfunction in a Pediatric Neuroimmunology Population | Peter V Sguigna, Morgan C McCreary, Darrel L Conger, Jennifer S Graves, Leslie A Benson, Amy T Waldman, Benjamin M Greenberg, PERCEPTION Collaboration | 2021-03 |
16 |
|
Why Therapeutic Compliance in Optic Neuritis Deserves to be More Than Just a Footnote | Anna M. Gruener, BMedSci(Hons), BMBS, MSc,FRCOphth, James M. A. Ellison, BMedSci(Hons), BMBS, PGDip,MRCPsych, Jessica R. Chang, MD | 2018-09 |
17 |
|
Why Therapeutic Compliance in Optic Neuritis Deserves to Be More Than Just a Footnote - Response | Mark Morrow, MD | 2018-09 |
18 |
|
Variation in Evolving Optic Neuritis | Marc A. Bouffard, MD, Robert M. Mallery, MD, Yaping J. Liao, MD, PhD, Nurhan Torun, MD | 2021-12 |
19 |
|
Anti-Asialo GM1 Antibody-Positive Optic Neuritis and Optic Perineuritis in Chronic Inflammatory Demyelinating Polyneuropathy | Celine Olivia, Melissa M. Chu, Subahari Raviskanthan, Peter W. Mortensen, Andrew G. Lee | 2022-09 |
20 |
|
Bilateral simultaneous optic neuritis in childhood systemic lupus erythematosus. | Hamid Ahmadieh, MD, Shahla Roodpeyma, MD, Mohsen Azarmina, MD, Massoud Soheilian, MD, S. Hamid Sajjadi, MD | 1994-06 |
21 |
|
Medical and Surgical Management of Acute Disseminated Encephalomyelitis | Brian D. Ellis, MD, Gregory S. Kosmorsky, DO, Bruce H. Cohen, MD | 1994-12 |
22 |
|
Delayed Diagnosis of Anti-Myelin Oligodendrocyte Glycoprotein One Decade After Presumed Recurrent Acute Disseminated Encephalomyelitis | Jason Zehden, Shruthi Harish Bindiganavile, Nita Bhat, Andrew G. Lee, Robert Avery, Karl C. Golnik | 2022-06 |
23 |
|
Evolution of Visual Outcomes in Clinical Trials for Multiple Sclerosis Disease-Modifying Therapies | Rachel C. Nolan, BA, Omar Akhand, BS, John-Ross Rizzo, MD, MSCI,Steven L. Galetta, MD, Laura J. Balcer, MD, MSCE | 2018-06 |
24 |
|
Comparison of 1.5 Tesla and 3.0 Tesla Magnetic Resonance Imaging in the Evaluation of Acute Demyelinating Optic Neuritis | Minjun Hur, Ajay A. Madhavan, David O. Hodge, Laurence J. Eckel, Sean J. Pittock, Eoin P. Flanagan, M. Tariq Bhatti, John J. Chen | 2022-09 |
25 |
|
Should Aquaporin-4 Antibody Test Be Performed in all Patients With Isolated Optic Neuritis? | Rosalynn G. Siantar; Farah N. I. Ibrahim; Hla M. Htoon; Sharon L. C. Tow; Kong Yong Goh; Jing Liang Loo; Su Ann Lim; Dan Milea; Melissa C. H. Tien; Zhiyong Chen; Tianrong Yeo; Josiah Y. H. Chai; Shweta Singhal; Chee Fang Chin; Kevin Tan | 2022-12 |